文献速递消化内镜消化道肿瘤与早癌

胃肠内镜中人工智能技术的监管考量

Regulatory considerations for artificial intelligence technologies in GI endoscopy.
PubMed 文献 · Gastrointest Endosc · 2020-06-03

本文综述了人工智能(AI)在胃肠内镜中的应用进展,重点介绍计算机辅助息肉检测(CADe)和计算机辅助息肉诊断(CADx),并描述当前AI工具在胃肠病学中的监管路径及其预期演变。

要点

  • AI在胃肠内镜中应用于计算机辅助息肉检测(CADe)和诊断(CADx)。
  • 随着临床证据积累,需关注AI技术对美国食品药品监督管理局等监管机构带来的独特挑战。
  • 本文描述了当前AI工具在胃肠病学中的监管路径及预期演变。

核心结论

  • 随着CADe和CADx临床证据的积累,注意力必须转向这些新技术对美国食品药品监督管理局和其他监管机构带来的独特挑战。

研究设计与样本

  • 本文为综述,描述了人工智能工具在胃肠病学中的当前监管路径及其预期演变。

主要发现

  • 人工智能在从病理学到放射学等领域已展示出改善临床性能和效率的潜力。
  • 在胃肠病学中,人工智能已在多个方面应用,尤其在计算机辅助息肉检测(CADe)和计算机辅助息肉诊断(CADx)领域取得进展,以辅助胃肠病学家进行结肠镜检查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence (AI) technologies in clinical medicine have become the subject of intensive investigative efforts and popular attention. In domains ranging from pathology to radiology, AI has demonstrated the potential to improve clinical performance and efficiency. In gastroenterology, AI has been applied on multiple fronts, with particular progress seen in the areas of computer-aided polyp detection (CADe) and computer-aided polyp diagnosis (CADx), to assist gastroenterologists during colonoscopy. As clinical evidence accrues for CADe and CADx, our attention must also turn toward the unique challenges that this new wave of technologies represent for the U.S. Food and Drug Administration and other regulatory agencies, who are tasked with protecting public health by ensuring the safety of medical devices. In this review, we describe the current regulatory pathways for AI tools in gastroenterology and the expected evolution of these pathways.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Walradt T, Glissen Brown JR, Alagappan M, et al. Regulatory considerations for artificial intelligence technologies in GI endoscopy. Gastrointest Endosc. 2020. PMID: 32504697. doi:10.1016/j.gie.2020.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。